Y-BOX BINDING PROTEIN YB-1 IDENTIFIES HIGH-RISK PRIMARY BREAST CANCER PATIENTS BENEFITING FROM RAPIDLY CYCLED TANDEM HIGH-DOSE ADJUVANT CHEMOTHERAPY

被引：0
|
作者：
Gluz, O. [1 ]
Mengele, K.
Schmitt, M. [2 ]
Kates, R.
Diallo-Danebrock, R. [3 ]
Royer, H. [4 ]
Eckstein, N. [4 ]
Mohrmann, S. [3 ]
Nitz, U. [1 ]
Harbeck, N. [5 ]
机构：
[1] Breast Clin Niederrhein, W German Study Grp, Monchengladbach, Germany
[2] Tech Univ Munich, Clin Gynaecol & Obstet, Munich, Germany
[3] Univ Duesseldorf, Dusseldorf, Germany
[4] CAESAR, Bonn, Germany
[5] Tech Univ Munich, Klinikum Rechts Isar, Frauenklin, D-8000 Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [31] Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry
    Pedrazzoli, Paolo
    Martinelli, Giovanni
    Gianni, Alessandro Massimo
    Da Prada, Gian Antonio
    Ballestrero, Alberto
    Rosti, Giovanni
    Frassineti, Giovanni Luca
    Aieta, Michele
    Secondino, Simona
    Cinieri, Saverio
    Fedele, Roberta
    Bengala, Carmelo
    Bregni, Marco
    Grasso, Donatella
    De Giorgi, Ugo
    Lanza, Francesco
    Castagna, Luca
    Bruno, Barbara
    Martino, Massimo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (04) : 501 - 506
  • [32] Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer
    Tallman, MS
    Gray, R
    Robert, NJ
    LeMaistre, CF
    Osborne, CK
    Vaughan, WP
    Gradishar, WJ
    Pisansky, TM
    Fetting, J
    Paietta, E
    Lazarus, HM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01): : 17 - 26
  • [33] High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes
    Stuart, MJ
    Peters, WP
    Broadwater, G
    Hussein, A
    Ross, M
    Marks, LB
    Folz, RJ
    Long, GD
    Rizzieri, D
    Chao, NJ
    Vredenburgh, JJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (12) : 666 - 673
  • [34] High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer Reply
    Steenbruggen, Tessa G.
    Steggink, Lars C.
    Sonke, Gabe S.
    JAMA ONCOLOGY, 2020, 6 (08) : 1300 - 1300
  • [35] ADJUVANT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL SUPPORT FOR 1183 HIGH-RISK PRIMARY BREAST CANCER PATIENTS: FINAL RESULTS FROM THE ITALIAN NATIONAL REGISTRY
    Pedrazzoli, P.
    Martino, M.
    Castagna, L.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S67 - S67
  • [36] High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer
    Bearman, SI
    Shpall, EJ
    Jones, RB
    Cagnoni, PJ
    Ross, M
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 60 - 67
  • [37] Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
    Somlo, G
    Simpson, JF
    Frankel, P
    Chow, W
    Leong, L
    Margolin, K
    Morgan, R
    Raschko, J
    Shibata, S
    Forman, S
    Kogut, N
    McNamara, M
    Molina, A
    Somlo, E
    Doroshow, JH
    BRITISH JOURNAL OF CANCER, 2002, 87 (03) : 281 - 288
  • [38] Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
    G Somlo
    J F Simpson
    P Frankel
    W Chow
    L Leong
    K Margolin
    R Morgan
    J Raschko
    S Shibata
    S Forman
    N Kogut
    M McNamara
    A Molina
    E Somlo
    J H Doroshow
    British Journal of Cancer, 2002, 87 : 281 - 288
  • [39] Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients
    Moebus, Volker
    BREAST CARE, 2016, 11 (01) : 8 - 12
  • [40] Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer
    Hohaus, S
    Martin, S
    Schneeweiss, A
    Voso, MT
    Schlenk, RF
    Wallwiener, D
    Bastert, G
    Haas, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (Suppl 1) : S13 - S17
12345